Standardization of flow cytometric minimal residual disease assessment in international clinical trials - a feasibility study from the European Myeloma Network.Davine Hofste op Bruinink,Stefania Oliva,Lucie Rihova,Alexander Schmitz,Milena Gilestro,Jeroen Te Marvelde,Romana Kralova,Helle Høholt,Annemiek Broijl,Hans Erik Johnsen,Roman Hajek,Mario Boccadoro,Pieter Sonneveld,Paola Omedè,Vincent H J Van der VeldenHaematologica（2020）引用 11|浏览63暂无评分AI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
